Journal for ImmunoTherapy of Cancer

Published by: Biomed Central Ltd  

People

  1. Budhu
    Budhu
  2. Liu
    Liu
  3. Zhong
    Zhong
  4. Hirschhorn Cymerman
    Hirschhorn Cymerman
  5. Postow
    Postow
  6. Yang
    Yang
  7. Abdel-Wahab
    Abdel-Wahab
  8. Barker
    Barker
  9. Blasberg
    Blasberg
  10. George
    George

Groups

  1. Sloan Kettering Institute Postdocs (24)
  2. Department of Medicine (23)
  3. Solid Tumor Oncology Division (23)
  4. Melanoma and Immunotherapeutics Service (21)
  5. GSK Faculty (18)
  6. MSK Grad Students (9)
  7. Melanoma Disease Management Team (7)
  8. Hematologic Malignancies, Division of (5)
  9. Radiation Oncology, Department of (4)
  10. Weinberg Fellows (4)
Search Within
  1. "Roberta Zappasodi"
Formats
  1. Meeting Abstract (21)
  2. Guidelines (1)
  3. Journal Article (1)
  4. Review (1)
Groups
  1. Sloan Kettering Institute Postdocs (24)
  2. Department of Medicine (23)
  3. Solid Tumor Oncology Division (23)
  4. Melanoma and Immunotherapeutics Service (21)
  5. GSK Faculty (18)
  6. MSK Grad Students (9)

More Groups

People
  1. Roberta Zappasodi (24)
  2. Taha Merghoub (20)
  3. Jedd Wolchok (18)
  4. Sadna Budhu (12)
  5. Levi Mark Mangarin (7)
  6. Cailian Liu (6)

More People

Years
  1. 2022 (1)
  2. 2021 (3)
  3. 2020 (5)
  4. 2019 (3)
  5. 2018 (4)
  6. 2017 (4)

More Years

Publishers
  1. Biomed Central Ltd (24)

Results (24)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Apr-246 induces an increase in tumor immunogenicity in a p53 independent manner
    Meeting Abstract

    Venkatesh, D.; Michels, J.; Lu, C.; Budhu, S.; George, M.; Ouerfelli, O.; Abrahmsen, L.; Zappasodi, R.; Wolchok, J.; Merghoub, T.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • MHC-I skewing in mutant calreticulin-positive myeloproliferative neoplasms is countered by heteroclitic peptide cancer vaccination
    Meeting Abstract

    Gigoux, M.; Zappasodi, R.; Park, J.; Bozkus, C. C.; Mangarin, L.; Redmond, D.; Verma, S.; Schad, S.; George, M.; Venkatesh, D.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Pharmacologic modulation of tumor glycolysis to improve responses to immune checkpoint blockade therapy
    Meeting Abstract

    Verma, S.; Maniyar, R.; Ko, M.; Budhu, S.; Serganova, I.; Zappasodi, R.; Blasberg, R.; Merghoub, T.; Wolchok, J.; Mangarin, L.
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Fifteen-year follow-up of relapsed indolent non-Hodgkin lymphoma patients vaccinated with tumor-loaded dendritic cells
    Journal Article

    Fucà, G.; Ambrosini, M.; Agnelli, L.; Brich, S.; Sgambelluri, F.; Mortarini, R.; Pupa, S. M.; Magni, M.; Devizzi, L.; Matteucci, P.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Characterizing double positive T cells in the tumor microenvironment: A tale of promiscuous cell fates
    Meeting Abstract

    Schad, S.; Chow, A.; Pan, H.; Mangarin, L.; Zappasodi, R.; Gigoux, M.; Redmond, D.; Hirschhorn-Cymerman, D.; Budhu, S.; Zhong, H.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • MHC-I skewing in mutant calreticulin-positive myeloproliferative neoplasms is countered by heteroclitic peptide cancer vaccination
    Meeting Abstract

    Gigoux, M.; Zappasodi, R.; Park, J.; Pourpe, S.; Ghosh, A.; Bozkus, C. C.; Mangarin, L.; Redmond, D.; Verma, S.; Schad, S.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • CTLA-4 blockade promotes Treg glucose metabolism and reduces Treg functional stability in glycolysis-defective tumors
    Meeting Abstract

    Zappasodi, R.; Serganova, I.; Cohen, I.; Maeda, M.; Senbabaoglu, Y.; Shindo, M.; Maniyar, R.; Mane, M.; Leftin, A.; Watson, M.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Construction of the immune landscape of durable response to checkpoint blockade therapy by integrating publicly available datasets
    Meeting Abstract

    Rudqvist, N. P.; Zappasodi, R.; Wells, D.; Thorsson, V.; Cogdill, A.; Monette, A.; Najjar, Y.; Sweis, R.; Wennerberg, E.; Bommareddy, P.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Defining tumor resistance to PD-1 pathway blockade: Recommendations from the first meeting of the SITC Immunotherapy Resistance Taskforce
    Guidelines

    Kluger, H. M.; Tawbi, H. A.; Ascierto, M. L.; Bowden, M.; Callahan, M. K.; Cha, E.; Chen, H. X.; Drake, C. G.; Feltquate, D. M.; Ferris, R. L.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Laminar Wash™ AUTO system: A reliable walk-away sample preparation solution for better TIL recovery without centrifugation
    Meeting Abstract

    Kim, I.; Lye, M.; Zappasodi, R.; Schulze, I.; Eberle, C.; Ke, C. Y.; Cheng, K. L.; Kon, I. C.; Pek, R.; Merghoub, T.; more...
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save

    • Journal for ImmunoTherapy of Cancer – authorized name for:

    Name ISSN / ISBN Publisher
    Journal for ImmunoTherapy of Cancer 2051-1426 Biomed Central Ltd
    Journal for ImmunoTherapy of Cancer 2051-1426 Biomed Central Ltd
    Journal for ImmunoTherapy of Cancer 20511426 Biomed Central Ltd
    Journal for Immunotherapy of Cancer BMJ Publishing Group Ltd.
    Journal for ImmunoTherapy of Cancer 2051-1426 Biomed Central Ltd
    Journal for Immunotherapy of Cancer BMJ Publishing Group Ltd.
    Journal for ImmunoTherapy of Cancer 2051-1426 Biomed Central Ltd
    Journal for ImmunoTherapy of Cancer 20511426 Author(s) (or Their Emp Oyer(s)) 2025
    Journal for ImmunoTherapy of Cancer 20511426 Unknown
    Journal for ImmunoTherapy of Cancer 2051-1426 Biomed Central Ltd
    Journal for ImmunoTherapy of Cancer 2051-1426 Biomed Central Ltd
    Journal for ImmunoTherapy of Cancer 20511426 Author(s) (or Their Employer(s)) 2025
    Journal for ImmunoTherapy of Cancer 2051-1426 Biomed Central Ltd
    Journal for ImmunoTherapy of Cancer 20511426 The Author(s)
    Journal for ImmunoTherapy of Cancer 2051-1426 Biomed Central Ltd
    Journal for ImmunoTherapy of Cancer 2051-1426 Biomed Central Ltd
    Journal for ImmunoTherapy of Cancer 20511426 BMJ Group
    Journal for ImmunoTherapy of Cancer 2051-1426 Biomed Central Ltd
    Journal for ImmunoTherapy of Cancer 2051-1426 Biomed Central Ltd
    Journal for ImmunoTherapy of Cancer 2051-1426 Biomed Central Ltd
    Journal for ImmunoTherapy of Cancer 2051-1426 Biomed Central Ltd
    Journal for ImmunoTherapy of Cancer 2051-1426 Biomed Central Ltd
    Journal for Immunotherapy of Cancer 2051-1426 Bmc
    Journal for ImmunoTherapy of Cancer 20511426 Author(s) (or Their Employer(s)) 2024
    Journal for ImmunoTherapy of Cancer 2017 Nov 8-12 Biomed Central Ltd
    Journal for ImmunoTherapy of Cancer 2051-1426 Biomed Central Ltd
    Journal for ImmunoTherapy of Cancer 20511426 Bmj
    Journal for ImmunoTherapy of Cancer 2051-1426 Biomed Central Ltd
    Journal for ImmunoTherapy of Cancer 20511426 Author(s) (or Their Employer(s))
    Unknown (2051-1426) 2051-1426 Biomed Central Ltd